Fred Manby

Entos, Inc. is a company founded in 2019 and based in an undisclosed location. The American company is focused on disrupting therapeutic discovery with its cutting-edge platform, Orbnet, which combines AI-driven technology and automated synthetic development to rapidly design small-molecule therapeutics. The company's team is comprised of renowned scientists and engineers, including Chemistry Nobel Prize winner Frances Arnold, with world-class expertise in machine learning and software development, as well as computational and medicinal chemistry. The company was founded by Tom Miller and Fred Manby, and Tom Miller has been the CEO since incorporation.

Entos, Inc. is a company founded in 2019 and based in an undisclosed location. The American company is focused on disrupting therapeutic discovery with its cutting-edge platform, Orbnet, which combines AI-driven technology and automated synthetic development to rapidly design small-molecule therapeutics. The company's team is comprised of renowned scientists and engineers, including Chemistry Nobel Prize winner Frances Arnold, with world-class expertise in machine learning and software development, as well as computational and medicinal chemistry. The company was founded by Tom Miller and Fred Manby, and Tom Miller has been the CEO since incorporation.

Entos, Inc. is a company founded in 2019 and based in an undisclosed location. The American company is focused on disrupting therapeutic discovery with its cutting-edge platform, Orbnet, which combines AI-driven technology and automated synthetic development to rapidly design small-molecule therapeutics. The company's team is comprised of renowned scientists and engineers, including Chemistry Nobel Prize winner Frances Arnold, with world-class expertise in machine learning and software development, as well as computational and medicinal chemistry. The company was founded by Tom Miller and Fred Manby, and Tom Miller has been the CEO since incorporation.

Entos, Inc. is a company founded in 2019 and based in an undisclosed location. The American company is focused on disrupting therapeutic discovery with its cutting-edge platform, Orbnet, which combines AI-driven technology and automated synthetic development to rapidly design small-molecule therapeutics. The company's team is comprised of renowned scientists and engineers, including Chemistry Nobel Prize winner Frances Arnold, with world-class expertise in machine learning and software development, as well as computational and medicinal chemistry. The company was founded by Tom Miller and Fred Manby, and Tom Miller has been the CEO since incorporation.

Entos, Inc. is a company founded in 2019 and based in an undisclosed location. The American company is focused on disrupting therapeutic discovery with its cutting-edge platform, Orbnet, which combines AI-driven technology and automated synthetic development to rapidly design small-molecule therapeutics. The company's team is comprised of renowned scientists and engineers, including Chemistry Nobel Prize winner Frances Arnold, with world-class expertise in machine learning and software development, as well as computational and medicinal chemistry. The company was founded by Tom Miller and Fred Manby, and Tom Miller has been the CEO since incorporation.